INTRODUCTION
============

Cellular senescence is defined as a proliferative arrest of a cell, accompanied by phenotypic and physiological changes including enlarged and flattened cell morphology and the appearance of SA-β-gal activity at pH 6.0 ([@b1-bmb-50-528]), which is caused by a variety of cellular stressors, such as active oncogenes, DNA damage, and oxidative overload ([@b2-bmb-50-528]--[@b4-bmb-50-528]). In particular, oxidative stress is the most common factor that induces cellular senescence in a variety of mammalian cells, including fibroblasts, keratinocytes, and cancer cells ([@b5-bmb-50-528]--[@b7-bmb-50-528]). Excessive accumulation of intracellular ROS leads to an increase in cellular senescence ([@b8-bmb-50-528]) through the activation of cell cycle inhibitors, p16^INK4a^ and p21^WAF1/CIP^ ([@b9-bmb-50-528], [@b10-bmb-50-528]). Despite the increasing number of studies that have proposed the importance of redox homeostasis in the regulation of cellular aging, the characterization of major antioxidants governing cellular senescence and their underlying mechanisms have not yet been fully elucidated.

Peroxiredoxin (Prx) is a family of antioxidant enzymes that contain thiol groups, and their primary role is closely related to alleviation of cellular oxidative stress ([@b11-bmb-50-528]). In addition, Prxs are frequently involved in oxidative damage-associated diseases, tumorigenesis, and degenerative disorders such as Parkinson's and Alzheimer's disease ([@b12-bmb-50-528]--[@b14-bmb-50-528]). Previous reports have revealed that the function of Prx II is associated with anti-aging activity in mouse embryonic fibroblasts (MEFs) and hippocampal neurons, as evidenced by accelerated cellular senescence and age-related cognitive failure in Prx II^−/−^ MEFs and mice, respectively ([@b15-bmb-50-528]). Prx I is the most abundant and ubiquitously distributed of the six Prx members (I--VI) and is mainly characterized as a regulator of cell proliferation and differentiation ([@b16-bmb-50-528]). Similar to Prx II, the augmented expression of Prx I is often found in a variety of age-related diseases including cancers and neurodegenerative diseases ([@b17-bmb-50-528]). Despite the high similarity in sequence and function between Prx I and Prx II, the functional role of Prx I in senescence has not yet been clearly defined.

In this study, we demonstrated that a null mutation of Prx I led to the induction and accumulation of cellular senescence. *In vitro* Prx I^−/−^ MEFs displayed senescent phenotypes, including an enlarged and flattened morphology and high SA-β-gal activity, which may have been mediated by the elevation of ROS and p16^INK4a^ levels. Increased SA-β-gal activity in aged Prx I^−/−^ mice further supported the *in vivo* role of Prx I in cellular senescence. These findings will provide compelling evidence for the role of oxidative stress as a potential inducer of aging and increase the understanding of the molecular mechanism(s) underlying cellular senescence.

RESULTS
=======

Prx I-deficient MEFs exhibit senescence-like morphology changes and retarded cell proliferation
-----------------------------------------------------------------------------------------------

Primary MEFs were prepared from 13.5 day-old embryonic fetuses after natural mating between Prx I^+/−^ male and female mice, and were then genotyped and analyzed by western blotting analysis of Prx I. Compared to wild type (WT), expression of Prx I was decreased by approximately half in Prx I^+/−^ and completely disappeared and Prx I^−/−^ MEFs, respectively ([Fig. 1A](#f1-bmb-50-528){ref-type="fig"}). To investigate the functional role of Prx I in cellular senescence, WT and Prx I^−/−^ MEFs were observed under an inverted microscope and subjected to flow cytometry to examine morphological and cell size changes, the characteristic features of senescence. Microscopic observation revealed that Prx I^−/−^ MEFs were larger and flatter than WT MEFs ([Fig. 1B](#f1-bmb-50-528){ref-type="fig"}). Significant increases in the relative cell size of Prx I^−/−^ MEFs were detected by flow cytometry analysis ([Fig. 1C](#f1-bmb-50-528){ref-type="fig"}). In addition, cell proliferation was greatly reduced in Prx I^−/−^ MEFs compared to WT cells regardless of passage number (passage number 4--6) ([Fig. 1D](#f1-bmb-50-528){ref-type="fig"}). These results indicate that Prx I plays an important role in premature senescence, as revealed by the flattened cell morphology, reduced cell proliferation, and enlarged cell size after loss of Prx I expression.

Induction of cellular senescence by loss of Prx I
-------------------------------------------------

Since Prx I^−/−^ MEFs showed similar phenotypic changes as cells undergoing senescence, we evaluated whether Prx I^−/−^ MEFs also exhibit SA-β-gal activity, an established hallmark of cellular senescence ([Fig. 2A](#f2-bmb-50-528){ref-type="fig"}). Prx I^−/−^ MEFs had significantly increased SA-β-gal activity compared to Prx I^+/+^ MEFs ([Fig. 2B](#f2-bmb-50-528){ref-type="fig"}). The quantified levels of SA-β-gal staining revealed that the frequency of positive cells was higher in cells without Prx I expression ([Fig. 2C](#f2-bmb-50-528){ref-type="fig"}). Increased SA-β-gal activity was correlated with the passage number of cells, but this is probably mediated by spontaneous senescence in primary cell culture. We next set out to evaluate the *in vivo* functions of Prx I in cellular senescence by assessing SA-β-gal activity in various tissues and organs from Prx I^−/−^ mice at 15 months of age. Consistent with the results from primary cell culture, SA-β-gal activity was observed only in the aged Prx I-null mouse ([Fig. 2D](#f2-bmb-50-528){ref-type="fig"}), which further supports the role of Prx I in the aging process *in vivo*.

Prx I regulates ROS-induced cellular senescence
-----------------------------------------------

The induction of cellular senescence in primary cells is triggered by the accumulation of ROS ([@b18-bmb-50-528]). Based on previous studies, we hypothesized that Prx I deletion may generate oxidative stress, thereby inducing senescence in Prx I^−/−^ MEFs. To address this question, we examined intracellular ROS levels, an indicator of oxidative stress, by staining MEFs with CM-H~2~DCFDA. Flow cytometric and immunocytochemical analysis revealed a significant increase (\~2-fold) in ROS levels in Prx I^−/−^ MEFs compared to Prx I^+/+^ MEFs, implicating the important role of Prx I expression on oxidative stress ([Fig. 3A and B](#f3-bmb-50-528){ref-type="fig"}). Given the apparent regulation of ROS levels by Prx I expression, we blocked oxidative stress with N-acetyl-L-cysteine (NAC), a chemical antioxidant. The intention was to further demonstrate that elevated ROS levels induced by loss of Prx I correlated with induced cellular senescence in the presence of H~2~O~2~ for short- (days *in vitro*, DIV3) or long-term treatment (DIV5). Prx I^−/−^ MEFs displayed a higher frequency of SA-β-gal-positive senescent cells than Prx I^+/+^ MEFs after induction of oxidative stress with H~2~O~2~ treatment, suggesting the involvement of Prx I in the ROS scavenging system ([Fig. 3C](#f3-bmb-50-528){ref-type="fig"}). The reduction of SA-β-gal-positive cells in Prx I^−/−^ MEFs was comparable with Prx I^+/+^ MEFs upon NAC-induced oxidative stress blocking on DIV3, whereas it had little effect on DIV5.

Prx I suppresses cellular senescence via p16^INK4a^ expression
--------------------------------------------------------------

Previous studies suggested that cell cycle regulators, such as p16^INK4a^ and p21^WAF1/Cip1^, are highly associated with senescence induction in mouse and human cultured cells ([@b19-bmb-50-528]). Therefore, we examined whether Prx I regulates cell cycle regulators in the induction of cellular senescence to explore the underlying molecular mechanisms more closely. We showed that p16^INK4a^ expression was significantly increased but that there was a little effect on p21^WAF1/Cip1^ or cyclin D1 after Prx I deletion with the progression of cell passage ([Fig. 4A and B](#f4-bmb-50-528){ref-type="fig"}). Moreover, expression of proliferating cell nuclear antigen (PCNA), an important factor related to proliferation, was inversely correlated with p16^INK4a^ expression ([Fig. 4A](#f4-bmb-50-528){ref-type="fig"}). To further confirm that upregulation of p16^INK4a^ expression in Prx I^−/−^ MEFs was caused by Prx I deficiency, we re-introduced Prx I using adenoviral vectors. As shown in [Fig. 4C](#f4-bmb-50-528){ref-type="fig"}, the expression of p16^INK4a^ was downregulated by the exogenous induction of Prx I in a dose-dependent manner. Taken together, these results suggest that Prx I promotes cellular senescence by downregulating p16^INK4a^ expression ([Fig. 4D](#f4-bmb-50-528){ref-type="fig"}).

DISCUSSION
==========

An increasing number of studies have documented that an increase in oxidative stress contributes to cellular senescence and that ROS play a critical role in aging that is induced by oxidative damage ([@b5-bmb-50-528], [@b6-bmb-50-528], [@b8-bmb-50-528]). However, there are many unanswered questions regarding this relationship, including how ROS contribute to senescence induction and what the role of antioxidant enzymes are in age-related diseases. Previous studies from our and other laboratories indicated that inhibition of antioxidant enzymes such as superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (Gpx1), thioredoxin reductase 1 (TrxR1), or Prx II promotes stress-induced premature senescence in human and mouse fibroblasts ([@b15-bmb-50-528], [@b20-bmb-50-528]--[@b23-bmb-50-528]). These studies implied that the loss of the ability to scavenge ROS during senescence was generally attributed to a decrease in the activity of antioxidant enzymes.

Prx I is known to play an important role in protecting against oxidative stress. Prx I^−/−^ mice showed increased oxidative damage to both DNA and protein ([@b24-bmb-50-528]). Consistent with these studies, our results demonstrate that the presence of senescent cells in Prx I^−/−^ MEFs is highly associated with increased ROS levels, indicating that Prx I protects cells from oxidative damage by scavenging ROS ([Fig. 3](#f3-bmb-50-528){ref-type="fig"}). In addition, we showed that the inhibitory effect of antioxidant NAC on cellular senescence were continuously detected in wild type MEFs regardless of culture periods, whereas it was not observed in Prx I^−/−^ MEFs cultured in long periods ([Fig. 3C](#f3-bmb-50-528){ref-type="fig"}), indicating that different mechanisms might be involved in the cellular senescence induced by the loss of Prx I, oxidative stress independent senescence. Furthermore, our data clearly show that Prx I suppresses cellular senescence by regulating p16^INK4a^ expression ([Fig. 4](#f4-bmb-50-528){ref-type="fig"}). Although it has been reported that ROS induces p16^INK4a^ expression ([@b25-bmb-50-528]), the physiological significance and the mechanisms underlying Prx I function remain to be elucidated. Therefore, our findings may provide new regulatory mechanisms of Prx I in inhibiting senescence through the regulation of the ROS-p16^INK4a^ expression. However, we still cannot rule out other regulatory mechanisms involved in Prx I-mediated senescence. Recently, it was reported that Prx I play a pivotal role in redox-regulated senescence by regulating p38 MAPK activity via modulating two p38 MAPK phosphatases, MAP kinase phosphatase 1 (MKP-1) and MKP-5 ([@b26-bmb-50-528]). It is possible that the concerted action of diverse regulatory mechanisms yield maximal consequences of Prx I in the modulation of senescence induced by oxidative stress.

Response to senescence are widely recognized as a barrier against tumorigenesis ([@b18-bmb-50-528], [@b27-bmb-50-528], [@b28-bmb-50-528]); however, senescence and tumorigenesis are positively linked ([@b29-bmb-50-528], [@b30-bmb-50-528]), suggesting that senescence might precede and/or sustain tumorigenesis. For instance, increased expression of p16^INK4a^ has also been detected in several tumors ([@b31-bmb-50-528]), and activated oncogenes such as Ras or Myc are able to induce senescence and tumorigenesis simultaneously ([@b32-bmb-50-528], [@b33-bmb-50-528]). It is likely that the senescence triggered by oncogenic activation plays an important role as a natural physiological response to tumor development. Prx I is frequently elevated in various human cancers and is used as a potential prognostic marker. Recently, both our group and the Neumann group demonstrated that Prx I^−/−^ mice have an increase likelihood of developing a tumor by activating oncogenic Ras ([@b34-bmb-50-528], [@b35-bmb-50-528]). As shown in [Supplementary Fig. 1](#s1-bmb-50-528){ref-type="supplementary-material"}, loss of Prx I induced cellular senescence with slow cell proliferation in the early passage (before passage 15). However, Prx I^−/−^ MEFs escaped senescence and grew rapidly and maintained high proliferation rate after 15 passages. Finally, Prx I^−/−^ MEFs acquired immortalized features with uncontrolled division at early passage compared to primary MEFs (15^th^ passage vs. 20^th^ passage). Therefore, it is possible that promotion of senescence by the absence of Prx I activates tumorigenesis. Further studies are required to fully understand how cellular senescence that is induced by Prx I affects tumorigenesis. This relationship could explain the dramatically increased incidence of cancer with advanced age. In conclusion, this study showed, for the first time, the functional role of Prx I as a novel regulator in cellular senescence.

MATERIALS AND METHODS
=====================

Preparation of the MEFs
-----------------------

Primary MEFs were prepared from 13.5 days post-coitum fetuses after natural mating between Prx I^+/−^ male and female mice as previously described ([@b15-bmb-50-528]). Wild-type (WT) and Prx I^−/−^ MEFs were cultured in Dulbecco's modified Eagle medium (DMEM; Gibco), supplemented with 200 unit/ml penicillin-G-sodium, 100 μg/ml streptomycin (Sigma-Aldrich), 4 mM L-glutamine and 10% fetal bovine serum (FBS; Hyclone).

Cell proliferation assay
------------------------

MEFs were seeded at a density of 2 × 10^4^ of cells in a 6-well plate, sampled by trypsinization, and stained by trypan blue dye. Subsequently, the cells were mounted onto a haematocytometer, and the cell number was counted under inverted microscope (Olympus).

SA-β-gal activity staining
--------------------------

SA-β-gal activity staining was performed using 5-bromo-4-chloro-3-indolyl-β-D-galactosidase (X-gal) according to the manufacturer's instructions (Sigma-Aldrich). Quantification of SA-β-gal-positive cells was obtained by counting five random fields per dish and assessing the percentage.

Measurement of intracellular ROS levels
---------------------------------------

Intracellular ROS generation was assessed with an 5,6-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H~2~DCFDA; Invitrogen), a ROS indicator. Exponentially growing MEFs were incubated with 5 μM CM-H2DCFDA at 37°C for 15 min and washed twice with PBS by centrifugation at 200 × g for 5 min. The cells were resuspended with PBS and analyzed by flow cytometry on a FACSCalibur instrument (BD Biosciences).

Chemical treatment
------------------

Hydrogen peroxide (H~2~O~2~; Sigma-Aldrich) previously diluted with sterile PBS was added to cell cultures at 20 μM in growth media. Antioxidant treatments with 5 mM N-acetyl-L-cysteine (NAC; Sigma-Aldrich) were performed 30 min before the addition of H~2~O~2~ to prevent oxidative stress.

Tissue preparation
------------------

WT and Prx I^−/−^ mice at 15 months of age were sacrificed under anesthesia administered by intraperitoneal injection of pentobarbital sodium (50 mg/kg body weight). For SA-β-gal histochemistry, multiple tissue types were frozen in liquid nitrogen, and embedded in Optimal Cutting Temperature (OCT) compound (Tissue-Tek). After air drying for 30 min, sections were fixed in 1% formalin for 1 min, washed in PBS, dried, and stored at −80°C until used for SA-β-gal staining.

Western blot analysis and antibodies
------------------------------------

Cells harvested after treatment were lysed in RIPA buffer and subjected to western blot analysis as described previously ([@b23-bmb-50-528]). Antibodies were obtained from Prx I (Abfrontier); PCNA (DakoCytomation); Cyclin D1 (Cell Signaling Technology); p16^INK4a^ and p21^WAF1/Cip1^ (Santa Cruz); β-actin (Sigma-Aldrich).

Adenovirus production for Prx I
-------------------------------

Recombinant replication-deficient adenoviruses were used in this study. Adenovirus containing Prx I cDNA was a kind gift from Dr. Sang Won Kang (Ewha Womans University, Seoul, Korea), Large-scale amplification of the adenovirus was performed as previously described ([@b34-bmb-50-528]). In brief, HEK 293 cells were transfected with adenoviral vector (multiplicity of infection = 2), and the replicated virus particles were concentrated by ultracentrifugation with a CsCl gradient. Viral titers were determined with a TCD50 assay (Adeno-Quest). Purified and concentrated adenovirus particles with titers ranging from 10^9^ to 10^11^ PFU/ml were suspended in 10 mM Tris-HCl (pH 8.0), 2 mM MgCl~2~, and 5% sucrose. For *in vitro* infection with adenovirus, MEFs were plated at a density of 1 × 10^6^ cells per well in 6-well cell culture plates (Corning) with DMEM plus 2% FBS containing the recombinant adenovirus at a concentration of 200 plaque-forming units (PFU) per cell as previously described ([@b36-bmb-50-528], [@b37-bmb-50-528]).

Quantitative Real-time PCR analysis
-----------------------------------

Total RNA was isolated from WT and Prx I^−/−^ MEFs at each passage using TRIZOL (Invitrogen) according to the manufacturer's instructions. For cDNA synthesis, 1 μg of total RNA was used in a 20 μl reaction mixture constituted using Maxime RT PreMix kit (Intron Biotechnology), and cDNA synthesized with oligo (dT) primers with the first-strand cDNA Synthesis kit (Toyobo) was mixed with the SYBR Premix Ex Taq (TaKaRa) and sets of gene-specific primers. Prx I (NM_011034.4) forward: 5′-tacgactagtccaggccttcc-3′ reverse: 5′-gtccagtgctcacttctgctt-3′; Cyclin D1 (NM_007631.2) forward: 5′-gcaagcatgcacagacctt-3′ reverse: 5′-gttgtgcggtagcaggaga-3′; p16^INK4a^ (NM_001040654.1) forward: 5′-gtgtgcatgacgtgcggg-3′; reverse: 5′-acgtgaacgttgcccat cat-3′; p21^WAF1/Cip1^ (NM_007669.5) forward: 5′-gtggggtgaggagg agcatg-3′ reverse: 5′-tgtgcggaacaggtcggaca-3′; β-actin (NM_007393.5) forward: 5′-cactgtcgagtcgcgtcc-3′; reverse: 5′-cgcag cgatatcgtcatcca-3′. The resulting mixture was subjected to real-time RT-PCR quantification with the Mx QPCR Systems (Agilent). Primers for PCR were designed using the Primer3 software program. The specificity of primers was verified by BLAST analysis of the mouse and human genome, visualized by RT-PCR products after agarose gel electrophoresis, and analyzed by the melting point of the PCR products.

Statistical analyses
--------------------

Experimental differences were tested for statistical significance using ANOVA and Student's t test on SigmaPlot 12.3 software. P value of \< 0.05 was considered to be significant.
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![Prx I^−/−^ MEFs show persistent growth arrest and induce senescence-associated phenotypic changes. (A) MEFs derived from different Prx I genotypes were generated and maintained by a defined 3T3 protocol. (B) Prx I^+/+^ or Prx I^−/−^ MEFs images were captured at 4 passage under a differential interference contrast (DIC) microscopy. (C) Cell sizes of the indicated MEFs were assessed by measuring forward light scatter (FSC) via flow cytometry. 4P, 4 passage; 6P, 6 passage. Data represent Mean ± SD (*n* = 3). \*P \< 0.05. (D) The population doubling level was calculated for Prx I^+/+^ or Prx I^−/−^ MEFs at each passage every 2 days (upper panel) and cells were counted at 7 days *in vitro* (DIV) (lower panel). Data represent Mean ± SD (*n* = 3). \*P \< 0.05, \*\*P \< 0.01.](bmb-50-528f1){#f1-bmb-50-528}

![Prx I deletion induceds cellular senescence both *in vitro* and *in vivo*. (A) Representative SA-β-gal staining images of early-and late-passage Prx I^+/+^ MEFs were shown. (B) Representative images of Prx I^+/+^ and Prx I^−/−^ MEFs stained for SA-β-gal at 8 passage. (C) Prx I^+/+^ and Prx I^−/−^ MEFs were stained for SA-β-gal at each passage from 3 to 11. SA-β-gal positive cells were counted in at least 10 fields from triplicate plates. Data represent Mean ± SD (*n* = 3). \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001. (D) The Liver, the lung, the intestine, and the uterus of Prx I^−/−^ mice were examined by SA-β-gal staining and compared to those of the Prx I^+/+^ mice. Black arrows indicate that SA-β-gal positive cells.](bmb-50-528f2){#f2-bmb-50-528}

![Involvement of ROS in Prx I-induced cellular senescence. (A) Expression level of Prx I was examined with immunocytochemistry (ICC) in MEFs (upper panel). Images were counterstained with DAPI. ROS production was detected by the fluorescent CM-H2DCFDA using fluorescence microscopy (lower panel). (B) Intracellular ROS levels were analyzed by flow cytometry (upper panel). Data represent Mean ± SD (*n* = 3). \*P \< 0.05. (lower panel). (C) The percentage of cells positively stained for the SA-β-gal activity in MEFs were pre-treated with presence or absence of either 5 mM NAC or 20 μM H~2~O~2~ at DIV 3 and 5. SA-β-gal positive cells were counted in at least 10 fields from triplicate plates. Data represent Mean ± SD (*n* = 3). \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001.](bmb-50-528f3){#f3-bmb-50-528}

![Prx I deficiency leads to up-regulation of p16^INK4a^ in MEFs. (A) Western blot analysis of Prx I, PCNA, p16^INK4a^, p21^WAF1/Cip1^, Cyclin D1, and β-actin in MEFs at each passage. (B) mRNA expressions were analyzed by quantitative Real-time PCR in MEFs from WT and Prx I^−/−^ for 3 to 7 passages. (C) Prx I^−/−^ MEFs were infected with recombinant adenovirus expressing human Prx I in a dose-dependent manner. Prx I and p16^INK4a^ expressions were assessed by western blot using cell extracts. (D) Schematic illustration of essential role of Prx I regulate ROS/p16^INK4a^ expression during cellular senescence by serial passage.](bmb-50-528f4){#f4-bmb-50-528}
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